We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.9B
1-Year Est. Return 23.65%
This Fund
S&P 500
This Quarter Est. Return
+15.25%
1 Year Est. Return
+23.65%
3 Year Est. Return
+66.72%
5 Year Est. Return
+71.27%
10 Year Est. Return
+298.51%
AUM
$2.49B
AUM Growth
+$561M
Cap. Flow
+$953M
Cap. Flow %
38.26%
Top 10 Hldgs %
19.27%
Holding
3,069
New
440
Increased
1,231
Reduced
593
Closed
189
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLR
901
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$169K 0.01%
6,428
-1,045
-14% -$15.6K
ALB icon
902
Albemarle
ALB
$15.5B
$168K 0.01%
1,170
-641
-35% -$76.1K
QPX icon
903
AdvisorShares Q Dynamic Growth ETF
QPX
$32.5M
$168K 0.01%
+6,611
New +$165K
VAW icon
904
Vanguard Materials ETF
VAW
$3.13B
$167K 0.01%
961
+299
+45% +$44K
DCP
905
DELISTED
DCP Midstream, LP
DCP
$165K 0.01%
7,617
-633
-8% -$9.95K
GRMN
906
Garmin
GRMN
$60B
$164K 0.01%
1,264
+172
+16% +$19K
LOB icon
907
Live Oak Bancshares
LOB
$1.97B
$164K 0.01%
+2,400
New +$96.2K
UPGD icon
908
Invesco Bloomberg Analyst Rating Improvers ETF
UPGD
$121M
$164K 0.01%
6,334
+2,526
+66% +$116K
BGR icon
909
BlackRock Energy and Resources Trust
BGR
$405M
$163K 0.01%
18,461
+12,520
+211% +$82.8K
OFLX icon
910
Omega Flex
OFLX
$312M
$163K 0.01%
1,041
-280
-21% -$44.2K
OILK icon
911
ProShares K-1 Free Crude Oil Strategy ETF
OILK
$190M
$163K 0.01%
3,000
SCHA icon
912
Schwab U.S Small- Cap ETF
SCHA
$23.1B
$163K 0.01%
6,740
+2,908
+76% +$57.9K
RVNC
913
DELISTED
Revance Therapeutics, Inc.
RVNC
$163K 0.01%
+6,040
New +$156K
VOE icon
914
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24B
$162K 0.01%
8,998
+7,847
+682% +$879K
NTAP icon
915
NetApp
NTAP
$37.2B
$161K 0.01%
2,173
+535
+33% +$28.3K
IMCG icon
916
iShares Morningstar Mid-Cap Growth ETF
IMCG
$4.09B
$160K 0.01%
2,550
IVZ icon
917
Invesco
IVZ
$13.9B
$160K 0.01%
8,141
+736
+10% +$11.3K
RQI icon
918
Cohen & Steers Quality Income Realty Fund
RQI
$1.69B
$160K 0.01%
11,615
+3,776
+48% +$44.1K
TRI icon
919
Thomson Reuters
TRI
$44.1B
$160K 0.01%
1,722
Z icon
920
Zillow
Z
$7.56B
$160K 0.01%
1,260
+1,240
+6,200% +$137K
TWST icon
921
Twist Bioscience
TWST
$7.25B
$159K 0.01%
+1,375
New +$153K
HYLV
922
DELISTED
IQ S&P High Yield Low Volatility Bond ETF
HYLV
$159K 0.01%
6,389
+1,181
+23% +$29.7K
BXMX
923
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
$158K 0.01%
11,943
-3,237
-21% -$38.8K
GAN
924
DELISTED
GAN Ltd
GAN
$158K 0.01%
7,929
-521
-6% -$8.73K
MFC icon
925
Manulife Financial
MFC
$73.5B
$158K 0.01%
7,371
+950
+15% +$15.2K

Similar funds

Geneos Wealth Management's Q4 2020 Portfolio in Review

As of Q4 2020, Geneos Wealth Management held 3,069 positions worth $2.49B, up 29% from $1.93B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Geneos Wealth Management deployed $953M of net new capital in Q4 2020, opening 440 new positions and adding to 1,231 existing holdings. Its largest new stake was ProShares Ultra Financials: 1,013,942 shares worth $53.6M.

By sector, the portfolio is most concentrated in Technology at 7.5% of assets, down from 7.9% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was iShares Core US Aggregate Bond ETF, an estimated $19.8M trimmed.

  • Geneos Wealth Management's largest Q4 2020 buy was ProShares Ultra Financials: 1,013,942 shares worth $53.6M.
  • Geneos Wealth Management added most to State Street SPDR Portfolio S&P 500 ETF in Q4 2020, an estimated $45M increase.
  • Geneos Wealth Management's biggest Q4 2020 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $19.8M.
  • Geneos Wealth Management fully exited CrossFirst Bankshares, Inc. Common Stock in Q4 2020, selling an estimated $1.18M.
  • Geneos Wealth Management's ten largest holdings make up 19% of its $2.49B portfolio in Q4 2020.
  • Geneos Wealth Management opened 440 new positions and closed 189 in Q4 2020.
  • Geneos Wealth Management's portfolio value rose 29% quarter-over-quarter to $2.49B.

Based on Geneos Wealth Management's 13F filing for Q4 2020, filed 19 May 2021.